Therapeutic agent for tumor
US8962650B2 · kind B2 · utility
12Cited by
78References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2012 |
| Grant date | Feb 24, 2015 |
| Priority date | — |
| Expiry date | Apr 16, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D215/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic agent for tumor for combined use of a compound or pharmaceutically acceptable salt thereof represented by Formula (I) and a compound represented by Formula (II):wherein R1 is C1-6 alkyl or C3-8 cycloalkyl, R2 is a hydrogen atom or C1-6 alkoxy, and R3 is a hydrogen atom or a halogen atom, exhibits an excellent antitumor effect compared to cases where these are individually used.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.